DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Exelixis (NASDAQ: EXEL)

3.44 -0.05 (-1.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXEL $3.44 -1.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.48
Previous Close $3.49
Daily Range $3.34 - $3.48
52-Week Range $1.26 - $4.55
Market Cap $674.3M
P/E Ratio -2.94
Dividend (Yield) $0.00 (0.0%)
Volume 1,867,752
Average Daily Volume 2,819,694
Current FY EPS -$0.79

Sector

Healthcare

Industry

Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary Rss Feed

Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!"

Exelixis' shareholders are about to have their patience tested, whether they like it or not.

Exelixis-Roche's Skin Cancer Drug's FDA Review Delayed - Analyst Blog

Seeking Alpha's Biotech Weekly: Celgene-Juno, Gilead's HIV NDA, Happy 4th!

Why Exelixis, Inc. Shares Slumped Today

Exelixis Inc.'s FDA review for approval of cobimetinib has been delayed until November.

10 Best Biotech Stocks in the NASDAQ

Small Cap Stocks to Watch in Biotech

Small cap stocks can be some of the most intriguing buys for investors. Here are three from the biotech sector that you may want to add to your watchlist.

The Drug Development Process Explained in Detail and How It Impacts Your Investments

A detailed step-by-step guide on how a drug goes from a concept in the lab to a product on pharmacy shelves, and how the drug development process can affect your investments.

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Benzinga's Top #PreMarket Losers

5 Stocks Leading XBI Biotech ETF Higher

See More EXEL News...

EXEL's Top Competitors

EXEL $3.44 (-1.43%)
Current stock: EXEL
ILMN $220.07 (-0.28%)
Current stock: ILMN
TMO $130.95 (0.10%)
Current stock: TMO
WAT $129.37 (0.26%)
Current stock: WAT